BioCentury | Nov 18, 2016
Clinical News

Biosimilar teriparatide regulatory update

...EMA's CHMP recommended approval of Terrosa/Movymia, a biosimilar of osteoporosis drug Forsteo teriparatide from Eli Lilly...
...as Terrosa and Stada Arzneimittel AG (Xetra:SAZ, Bad Vilbel, Germany) will launch the product as Movymia...
...Budapest:RICHTER), Budapest, Hungary Helm AG, Hamburg, Germany Product: Terrosa , Movymia biosimilar teriparatide Business: Musculoskeletal Chris Lieu Movymia Terrosa Gedeon...
BioCentury | Nov 11, 2016
Company News

CHMP recommendations include HBV drug Vemlidy

...A/S (CSE:ZEAL). CHMP also backed three biosimilars: Movymia teriparatide from Stada Arzneimittel AG (Xetra:SAZ) and Terrosa...
...& Co. Inc. (NYSE:MRK) to treat diabetes in patients aged two and older. Movymia and Terrosa...
Items per page:
1 - 2 of 2